Literature DB >> 16081034

Analysis of hyaluronan content in chondroitin sulfate preparations by using selective enzymatic digestion and electrospray ionization mass spectrometry.

Ola M Saad1, Richard A Myers, D Laird Castleton, Julie A Leary.   

Abstract

Two important glycosaminoglycans (GAGs) with structural roles in the body's cartilage are hyaluronan (HA) and chondroitin sulfate (CS). A simple mass spectrometric method for determining the amount of HA that may be present in isolated CS samples is presented in this article. Samples are subjected to selective enzymatic digestion using a bacterial hyaluronidase (HA lyase, EC 4.2.2, from Streptococcus dysgalactiae) specific for HA. Undigested CS GAG is then removed by centrifugal filtration, and digested HA left in the filtrate is quantified by electrospray ionization mass spectrometry using an internal standard and selected ion monitoring. The described method was applied to the analysis of several CS samples prepared for use in nutritional supplements.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081034     DOI: 10.1016/j.ab.2005.06.041

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  Differential Characterization and Classification of Tissue Specific Glycosaminoglycans by Tandem Mass Spectrometry and Statistical Methods.

Authors:  Nancy Leymarie; Mark E McComb; Hicham Naimy; Gregory O Staples; Joseph Zaia
Journal:  Int J Mass Spectrom       Date:  2011-07-23       Impact factor: 1.986

2.  Ultraperformance liquid chromatography with electrospray ionization ion trap mass spectrometry for chondroitin disaccharide analysis.

Authors:  Kemal Solakyildirim; Zhenqing Zhang; Robert J Linhardt
Journal:  Anal Biochem       Date:  2009-09-19       Impact factor: 3.365

3.  Tandem MS can distinguish hyaluronic acid from N-acetylheparosan.

Authors:  Zhenqing Zhang; Jin Xie; Jian Liu; Robert J Linhardt
Journal:  J Am Soc Mass Spectrom       Date:  2007-10-30       Impact factor: 3.109

Review 4.  Therapeutically targeting protein-glycan interactions.

Authors:  A Rek; E Krenn; A J Kungl
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.